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SCIENTIFIC OPINION 
Scientific Opinion on Flavouring Group Evaluation 87 Revision 1 
(FGE.87Rev1): 
Consideration of bicyclic secondary alcohols, ketones and related esters 
evaluated by JECFA (63rd meeting) structurally related to bicyclic 
secondary alcohols, ketones and related esters evaluated by EFSA in 
FGE.47 (2008)1 
EFSA Panel on Food Contact Materials, Enzymes, Flavourings and 
Processing Aids (CEF)2, 3 
European Food Safety Authority (EFSA), Parma, Italy 
ABSTRACT 
The Panel on Food Contact Materials, Enzymes, Flavourings and Processing Aids of the European 
Food Safety Authority was requested to consider evaluations of flavouring substances assessed since 
2000 by the Joint FAO/WHO Expert Committee on Food Additives (the JECFA), and to decide 
whether further evaluation is necessary, as laid down in Commission Regulation (EC) No 1565/2000. 
The present consideration concerns a group of 17 bicyclic secondary alcohols, ketones and related 
esters evaluated by the JECFA at the 63rd meeting in 2004. This revision of FGE.87 is made due to 
consideration of two additional substances [FL-no: 02.100 and 02.101] compared to previous version. 
Additionally, new information on EU production volume on two substances and information on 
stereoisomeric composition for 13 substances are also included. The substances were evaluated 
through a stepwise approach that integrates information on structure-activity relationships, intake from 
current uses, toxicological threshold of concern, and available data on metabolism and toxicity. The 
Panel agrees with the application of the Procedure as performed by the JECFA for all 17 substances 
considered in this FGE and agrees with the JECFA conclusion, “No safety concern at estimated levels 
of intake as flavouring substances” based on the MSDI approach. Besides the safety assessment of 
these flavouring substances, the specifications for the materials of commerce have also been 
                                                     
 
1  On request from the Commission, Question No EFSA-Q-2011-01047 and EFSA-Q-2011-01048 adopted on 2 February 
2012. 
2  Panel members Ulla Beckman Sundh, Mona-Lise Binderup, Leon Brimer, Laurence Castle, Karl-Heinz Engel, Roland 
Franz, Nathalie Gontard, Rainer Gürtler, Trine Husøy, Klaus-Dieter Jany, Catherine Leclercq, Jean Claude Lhuguenot, 
Wim Mennes, Maria Rosaria Milana, Iona Pratt, Kettil Svensson, Fidel Toldra, Detlef Wölfle. Correspondence: 
cef@efsa.europa.eu 
3  Acknowledgement: The Panel wishes to thank the members of the Working Group on Flavourings for the preparation of 
this Opinion: Ulla Beckman Sundh, Vibe Beltoft, Leon Brimer, Wilfried Bursch, Angelo Carere, Karl-Heinz Engel, 
Henrik Frandsen, Rainer Gürtler, Frances Hill, Trine Husøy, John Christian Larsen, Pia Lund, Wim Mennes, Gerard 
Mulder, Karin Nørby, Gerrit Speijers, Harriet Wallin and EFSA’s staff member Kim Rygaard Nielsen for the preparatory 
work on this scientific Opinion. 
 
Flavouring Group Evaluation 87, Revision 1
 
EFSA Journal 2012;10(2):2564 2
considered for the substances evaluated through the Procedure and for two substances, [FL-no: 02.100 
and 02.101], information on the stereoisomeric composition is lacking. 
 
© European Food Safety Authority, 2012 
KEY WORDS 
Flavouring, food safety, Bicyclic secondary alcohols, ketones and related esters, JECFA, secondary 
alicyclic saturated alcohols, secondary alicyclic unsaturated alcohols, FGE.47, FGE.87. 
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SUMMARY 
The Scientific Panel on Food Contact Materials, Enzymes, Flavourings and Processing Aids (the 
Panel) was asked to give scientific advice to the Commission on the implications for human health of 
chemically defined flavouring substances used in or on foodstuffs in the Member States. In particular, 
the Panel was requested to consider the Joint FAO/WHO Expert Committee on Food Additives (the 
JECFA) evaluations of flavouring substances assessed since 2000, and to decide whether no further 
evaluation is necessary, as laid down in Commission Regulation (EC) No 1565/2000. These 
flavouring substances are listed in the Register, which was adopted by Commission Decision 
1999/217/EC and its consecutive amendments. 
This consideration deals with 17 bicyclic secondary alcohols, ketones and related esters, which are in 
the Register and which were evaluated by the JECFA at its 63rd meeting.  
The revision is made due to consideration of two additional substances [FL-no: 02.100 and 02.101] 
compared to the previous version. These two substances are alpha,beta-unsaturated substances which 
have been considered with respect to genotoxicity in FGE.211 and FGE.212Rev1, and the Panel 
concluded that the data available  ruled out the concern for genotoxicity and thus concluded that the 
two substances can be evaluated through the Procedure in this FGE.87Rev1. EU production volume 
on two substances [FL-no: 09.153 and 09.319] and new information on stereoisomerism for 13 
substances [FL-no: 02.016, 02.038, 02.059, 07.159, 09.017, 09.082, 09.131, 09.153, 09.176, 09.218, 
09.319, 09.456 and 09.457] are also included. 
The Panel concluded that all 17 substances are structurally related to the group of four bicyclic 
secondary alcohols, ketones and related evaluated by EFSA in the Flavouring Group Evaluation 47 
(FGE.47). 
The Panel agrees with the application of the Procedure as performed by the JECFA for the 17 bicyclic 
secondary alcohols, ketones and related esters. It was concluded at step A3 of the Procedure that the 
17 substances do not pose a safety concern when used as flavouring substances at estimated levels of 
intake, based on the MSDI approach. 
For all 17 substances evaluated through the Procedure use levels are needed to calculate the 
mTAMDIs in order to identify those flavouring substances that need more refined exposure 
assessments and to finalise the evaluation. 
In order to determine whether the conclusion for the JECFA-evaluated substances can be applied to 
the materials of commerce, it is necessary to consider the available specifications. Specifications are 
available for all the materials of commerce. For two of the candidate substances [FL-no: 02.100 and 
02.101] the stereoisomeric composition has not been specified. Thus, for these two JECFA-evaluated 
substances [FL-no: 02.100 and 02.101] the Panel has reservations (information on the stereoisomeric 
composition is lacking). 
For the remaining 15 JECFA-evaluated substances [FL-no: 02.016, 02.038, 02.059, 07.153, 07.159 , 
09.017, 09.082, 09.131, 09.153, 09.176, 09.218, 09.269, 09.319, 09.456 and 09.457] the Panel agrees 
with the JECFA conclusion: “No safety concern at estimated levels of intake as flavouring substances” 
based on the MSDI approach. 
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BACKGROUND 
Regulation (EC) No 2232/96 of the European Parliament and the Council (EC, 1996a) lays down a 
Procedure for the establishment of a list of flavouring substances, the use of which will be authorised 
to the exclusion of all other substances in the EU. In application of that Regulation, a Register of 
flavouring substances used in or on foodstuffs in the Member States was adopted by Commission 
Decision 1999/217/EC (EC, 1999a), as last amended by Commission Decision 2009/163/EC (EC, 
2009a). Each flavouring substance is attributed a FLAVIS-number (FL-number) and all substances are 
divided into 34 chemical groups. Substances within a group should have some metabolic and 
biological behaviour in common. 
Substances which are listed in the Register are to be evaluated according to the evaluation programme 
laid down in Commission Regulation (EC) No 1565/2000 (EC, 2000a), which is broadly based on the 
Opinion of the Scientific Committee on Food (SCF, 1999a).  
Commission Regulation (EC) No 1565/2000 lays down that substances that are contained in the 
Register and will be classified in the future by the Joint FAO/WHO Expert Committee on Food 
Additives (the JECFA) so as to present no safety concern at current levels of intake will be considered 
by the European Food Safety Authority (EFSA), who may then decide that no further evaluation is 
necessary. 
In the period 2000 – 2008, during its 55th, 57th, 59th, 61st, 63rd, 65th, 68th and 69th meetings, the JECFA 
evaluated about 1000 substances, which are in the EU Register. 
TERMS OF REFERENCE 
EFSA is requested to consider the JECFA evaluations of flavouring substances assessed since 2000, 
and to decide whether no further evaluation is necessary, as laid down in Commission Regulation (EC) 
No 1565/2000 (EC, 2000a). These flavouring substances are listed in the Register which was adopted 
by Commission Decision 1999/217 EC (EC, 1999a) and its consecutive amendments. 
ASSESSMENT 
The approach used by EFSA for safety evaluation of flavouring substances is referred to in 
Commission Regulation (EC) No 1565/2000 (EC, 2000a), hereafter named the “EFSA Procedure”. 
This Procedure is based on the Opinion of the Scientific Committee on Food (SCF, 1999a), which has 
been derived from the evaluation procedure developed by the Joint FAO/WHO Expert Committee on 
Food Additives (JECFA, 1995; JECFA, 1996a; JECFA, 1997a; JECFA, 1999b), hereafter named the 
“JECFA Procedure”. The Panel on Food Contact Materials, Enzymes, Flavourings and Processing 
Aids (the Panel) compares the JECFA evaluation of structurally related substances with the result of a 
corresponding EFSA evaluation, focussing on specifications, intake estimations and toxicity data, 
especially genotoxicity data. The evaluations by EFSA will conclude whether the flavouring 
substances are of no safety concern at their estimated levels of intake, whether additional data are 
required or whether certain substances should not be put through the EFSA Procedure. 
The following issues are of special importance. 
Intake 
In its evaluation, the Panel as a default uses the “Maximised Survey-derived Daily Intake” (MSDI) 
approach to estimate the per capita intakes of the flavouring substances in Europe.  
In its evaluation, the JECFA includes intake estimates based on the MSDI approach derived from both 
European and USA production figures. The highest of the two MSDI figures is used in the evaluation 
by the JECFA. It is noted that in several cases, only the MSDI figures from the USA were available, 
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meaning that certain flavouring substances have been evaluated by the JECFA only on the basis of 
these figures. For Register substances for which this is the case the Panel will need EU production 
figures in order to finalise the evaluation. 
When the Panel examined the information provided by the European Flavour Industry on the use 
levels in various foods, it appeared obvious that the MSDI approach in a number of cases would 
grossly underestimate the intake by regular consumers of products flavoured at the use level reported 
by the Industry, especially in those cases where the annual production values were reported to be 
small. In consequence, the Panel had reservations about the data on use and use levels provided and 
the intake estimates obtained by the MSDI approach. It is noted that the JECFA, at its 65th meeting 
considered ”how to improve the identification and assessment of flavouring agents, for which the 
MSDI estimates may be substantially lower than the dietary exposures that would be estimated from 
the anticipated average use levels in foods” (JECFA, 2006c). 
In the absence of more accurate information that would enable the Panel to make a more realistic 
estimate of the intakes of the flavouring substances, the Panel has decided also to perform an estimate 
of the daily intakes per person using a “modified Theoretical Added Maximum Daily Intake” 
(mTAMDI) approach based on the normal use levels reported by Industry. 
As information on use levels for the flavouring substances has not been requested by the JECFA or 
has not otherwise been provided to the Panel, it is not possible to estimate the daily intakes using the 
mTAMDI approach for the substances evaluated by the JECFA. The Panel will need information on 
use levels in order to finalise the evaluation. 
Threshold of 1.5 Microgram/Person/Day (Step B5) Used by the JECFA 
The JECFA uses the threshold of concern of 1.5 microgram/person/day as part of the evaluation 
procedure: 
“The Committee noted that this value was based on a risk analysis of known carcinogens which 
involved several conservative assumptions. The use of this value was supported by additional 
information on developmental toxicity, neurotoxicity and immunotoxicity. In the judgement of the 
Committee, flavouring substances for which insufficient data are available for them to be evaluated 
using earlier steps in the Procedure, but for which the intake would not exceed 1.5 microgram per 
person per day would not be expected to present a safety concern. The Committee recommended that 
the Procedure for the Safety Evaluation of Flavouring Agents used at the forty-sixth meeting be 
amended to include the last step on the right-hand side of the original procedure (“Do the condition of 
use result in an intake greater than 1.5 microgram per day?”)” (JECFA, 1999b).  
In line with the Opinion expressed by the Scientific Committee on Food (SCF, 1999), the Panel does 
not make use of this threshold of 1.5 microgram per person per day. 
Genotoxicity 
As reflected in the Opinion of SCF (SCF, 1999a), the Panel has in its evaluation focussed on a 
possible genotoxic potential of the flavouring substances or of structurally related substances. 
Generally, substances for which the Panel has concluded that there is an indication of genotoxic 
potential in vitro will not be evaluated using the EFSA Procedure until further genotoxicity data are 
provided. Substances for which a genotoxic potential in vivo has been concluded, will not be evaluated 
through the Procedure. 
Specifications 
Regarding specifications, the evaluation by the Panel could lead to a different opinion than that of 
JECFA, since the Panel requests information on e.g. isomerism. 
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Structural Relationship  
In the consideration of the JECFA evaluated substances, the Panel will examine the structural 
relationship and metabolism features of the substances within the flavouring group and compare this 
with the corresponding FGE. 
HISTORY OF THE EVALUATION OF THE SUBSTANCES IN THE PRESENT FGE 
At its 63rd meeting the JECFA evaluated a group of 32 flavouring substances consisting of monocyclic 
and bicyclic secondary alcohols, ketones and related esters. Three substances were not in the Register, 
and six are alpha,beta-unsaturated ketones or precursors for such and these will be or have been 
considered together with other alpha,beta-unsaturated aldehydes and ketones (EFSA, 2008b) in 
FGE.213, FGE.211 and FGE.212 and revision hereof. One is an ether [FL-no: 16.088] considered in a 
revision of FGE.59 (FGE.59Rev1). Six are monocyclic secondary alcohols, ketones and related esters 
considered in FGE.56. Finally, the JECFA evaluated substance, (1R)-1,7,7-
Trimethylbicyclo[2.2.1]heptan-2-one (camphor [FL-no: 07.215]), which the Panel has evaluated in a 
separate Opinion (EFSA, 2008l). The remaining 15 flavouring substances were considered by EFSA 
in FGE.87 (EFSA, 2008az). 
FGE Opinion adopted 
by EFSA 
Link No. of candidate 
substances 
FGE.87 22 May 2008 http://www.efsa.europa.eu/en/efsajournal/pub/746.htm 15 
FGE.87Rev1 1 February 2012  17 
 
The present revision of FGE.87, FGE.87Rev1 includes the consideration of an additional two 
substances [FL-no: 02.100 and 02.101]. These two substances are precursors for alpha,beta-
unsaturated ketones and were allocated to FGE.211 and FGE.212Rev1, respectively. 
Since the publication of FGE.87, the EU production volume has been provided for two substances, 
[FL-no: 09.153 and 09.319] for which the evaluation could not be finalised in the previous version of 
this FGE, due to lack of these data. Based on the newly submitted EU production volume the 
substances have already been evaluated in FGE.96 (EFSA, 2010al), but for the sake of completion, the 
information has also been included here as well. 
Finally, new information on the stereoisomeric composition has been provided for 13 substances [FL-
no: 02.016, 02.038, 02.059, 07.159, 09.017, 09.082, 09.131, 09.153, 09.176, 09.218, 09.319, 09.456 
and 09.457] since the publication of FGE.87 (EFFA, 2010a; EFFA, 2011m). 
1. Presentation of the Substances in the JECFA Flavouring Group 
1.1. Description 
1.1.1. JECFA Status 
The JECFA has at the 63rd meeting evaluated a group of 32 flavouring substances consisting of 
monocyclic and bicyclic secondary alcohols, ketones and related esters (JECFA, 2006a). 
1.1.2. EFSA Considerations 
Three of the 32 JECFA evaluated substances are not included in the Register, alpha-isomethylionyl 
acetate (JECFA-no: 1410), d,l-menthol-(±)-propylene glycol carbonate (JECFA-no: 1413) and l-
monomenthyl glutarate (JECFA-no: 1414). 
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Six of the 32 JECFA evaluated substances are alpha,beta-unsaturated [FL-no: 02.100, 02.101, 07.089, 
07.136, 07.140 and 09.305] and will be or have been evaluated together with other alpha,beta-
unsaturated aldehydes and ketones (EFSA, 2008b). Two of these alpha,beta-unsaturated substances 
[FL-no: 02.100 and 02.101] have been considered with respect to genotoxicity in FGE.211 (EFSA, 
2011e) and FGE.212Rev1 (EFSA, 2011f). The Panel concluded that the data available ruled out the 
concern for genotoxicity and thus concluded that the two substances can be evaluated through the 
Procedure. 
One of the JECFA evaluated substances is an ether [FL-no: 16.088] which is considered together with 
other ethers in a revision of FGE.59 (FGE.59Rev1). Six of the JECFA evaluated substances are 
monocyclic secondary alcohols, ketones and related esters and are considered in FGE.56. Finally, the 
JECFA evaluated substance, (1R)-1,7,7-Trimethylbicyclo[2.2.1]heptan-2-one (camphor [FL-no: 
07.215]), the Panel evaluated in a separate Opinion (EFSA, 2008l). 
This consideration will therefore only deal with 17 bicyclic secondary alcohols, ketones and related 
esters. The Panel concluded that all substances in the JECFA flavouring group of bicyclic secondary 
alcohols, ketones and related esters are structurally related to the group of four bicyclic secondary 
alcohols, ketones and related esters evaluated by EFSA in FGE.47. 
1.2. Isomers 
1.2.1. JECFA Status 
All 17 Register substances have one or more chiral centres (see Table 1). 
1.2.2. EFSA Considerations  
For two of the substances [FL-no: 02.100 and 02.101] the composition of the mixture of stereoisomers 
has not been specified.   
For the two stereoisomeric substances [FL-no: 07.153 and 09.269] with one chiral centre, the CAS 
register number (CASrn) is considered to cover the stereoisomeric composition. 
1.3. Specifications 
1.3.1. JECFA Status 
JECFA specifications are available for all substances (JECFA, 2005b). 
1.3.2. EFSA Considerations 
The composition of the mixture has not been specified for two substances [FL-no: 02.100 and 02.101] 
(see Section 1.2.2). For two substances [FL-no: 02.059 and 07.153] the minimum assay is below 95 %, 
but information on secondary components is available in the specifications (see Table 1). 
2. Intake Estimations 
2.1. JECFA Status 
For all substances evaluated through the JECFA Procedure production figures are available for the 
EU.  
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2.2. EFSA Considerations 
No comment. 
3. Genotoxicity Data 
3.1. Genotoxicity Studies – Text taken4 from the JECFA (JECFA, 2006a) 
Tests for genotoxicity in vitro and in vivo using standardized protocols have been used to study two 
representative members [FL-no: 02.016 and 09.131] of the bicyclic secondary alcohols, ketones and 
related esters group used as flavouring agents. 
In vitro 
Two members of this group (borneol, [FL-no: 02.016] and isobornyl propionate, [FL-no: 09.131]) 
consistently gave negative results in the Ames assay when incubated at a concentration of up to 5000 
µg/plate with a variety of Salmonella typhimurium strains including TA97, TA98, TA100, TA1535, 
TA1537 and TA1538 with or without metabolic activation (Simmon et al., 1977; Wild et al., 1983; 
Azizan and Blevins, 1995). 
Borneol [FL-no: 02.016] showed no mutagenic activity when tested in Escherichia coli WP2 uvrA at 
concentrations of up to 3200 µg/plate (Yoo, 1986). 
In the Rec-assay, borneol [FL-no: 02.016] was reported to induce growth inhibition in Bacillus subtilis 
strain M45- when tested at concentrations of up to 10 mg/disc (Yoo, 1986). This test has very limited 
relevance for the genotoxicity evaluation. 
In vivo 
The potential of isobornyl propionate [FL-no: 09.131] to induce sex-linked recessive lethal mutations 
in adult Drosophila melanogaster was studied in a Basc test. No increased frequency of mutation was 
observed in flies fed with isobornyl propionate [FL-no: 09.131] in a 10 mmol/l solution for 3 days 
(Wild et al., 1983). 
In the test for micronucleus formation, groups of NMRI mice given isobornyl propionate (FL-no: 
09.131) at a dose of 841, 1893 or 2944 mg/kg body weight (bw) by intraperitoneal administration 
showed no increase in micronucleated erythrocytes in samples of bone marrow, 30 hours after 
administration (Wild et al., 1983). 
Conclusion on genotoxicity 
The testing of these representative bicyclic secondary alcohols, ketones and related esters in bacterial 
(Ames assay) and mammalian (micronucleus formation) in vivo systems showed no evidence of 
genotoxic potential, and these results are further supported by the lack of positive findings in the 
Drosophila Basc test. 
For a summary of in vitro / in vivo genotoxicity data considered by the JECFA, see Table 2.1. 
3.2. Genotoxicity Studies - Text taken from FGE.47 (EFSA, 2008at) 
No in vitro / in vivo genotoxicity data are available for the candidate substances in FGE.47. 
                                                     
 
4 The text is taken verbatim from the indicated reference source, but text related to substances not included in the present FGE has been removed. 
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3.3. Genotoxicity Studies - Text taken from FGE.211 (EFSA, 2011e) 
The following text is taken from FGE.211 and is relevant for the evaluation of pinocarveol [FL no: 
02.100], which was one of the four substances in subgroup 2.5 of FGE.19 (FGE.211) for which a 
conclusion of no concern for genotoxicity was reached. 
The Industry has submitted data concerning genotoxicity studies for a representative substance for this 
subgroup 2.5 of FGE.19, 1(7),8-p-menthadien-2-yl acetate [FL-no: 09.930] (structurally related to 
1(7),8-p-menthadien-2-one). 
In Vitro Data 
The newly available data comprise a bacterial reverse mutation assay and an in vitro micronucleus 
assay with human peripheral blood lymphocytes. The genotoxicity assays have been performed on a 
commercial mixture of the representative substance 1(7),8-p-menthadien-2-yl acetate and a positional 
isomer, carvyl acetate. Carvyl acetate can be hydrolysed, followed by oxidation, to carvone, which has 
been evaluated by EFSA in FGE.212 (EFSA, 2009ai) and NTP (NTP, 1990b) as non-genotoxic. The 
highest concentration of d-carvone that could be tested without cytotoxicity was 333 µg/plate 
(Mortelmans et al., 1986), i.e. the cytotoxicity was in the same range as observed for the mixture of 
1(7),8-p-menthadien-2-yl acetate/carvyl acetate. The Panel concluded that testing the commercial 
mixture of 1(7),8-p-menthadien-2-yl acetate/carvyl acetate for genotoxicity allows the evaluation of 
the genotoxic potential of 1(7),8-p-menthadien-2-yl acetate. The concentrations reported in Table 3 (in 
FGE.211) are for the mixture of substances. 
Bacterial Reverse Mutation Assay 
1(7),8-p-menthadien-2-yl acetate/carvyl acetate was tested for mutagenic activity according to OECD 
guideline 471 and in compliance with GLP (Beevers, 2010a). The test material exhibited a marked 
toxicity as indicated by thinning of the background lawn, reduced revertant counts and complete 
killing of test bacteria. However, the Panel considered the remaining number of concentrations 
without signs of toxicity sufficient to draw a conclusion on mutagenicity in this system (for details see 
FGE.211, Table 3).  
Overall, the Panel concluded that there was no evidence of mutagenic activity of 1(7),8-p-menthadien-
2-yl acetate/carvyl acetate at concentrations up to those causing bactericidal effects. 
In vitro Micronucleus Test 
1(7),8-p-menthadien-2-yl acetate/carvyl acetate was tested for induction of micronulei in human 
peripheral blood lymphocytes according to OECD guideline 487 and in compliance with GLP 
(Whitwell, 2010b). The Panel considered that acceptable levels of cytotoxicity as judged upon the 
replication index were achieved at the top concentrations (for details see FGE.211 Table 3).  
Overall, the Panel concluded that there was no evidence of chromosomal damage or aneuploidy, as 
evidenced by no increase in levels of micronucleated binucleate cells (MNBN) in the presence or 
absence of S9 metabolic activation. 
Discussion of Mutagenicity/Genotoxicity Data 
The commercial mixture of the representative substance 1(7),8-p-menthadien-2-yl acetate and a 
positional isomer, carvyl acetate was tested for all three genetic endpoints: gene mutations, structural 
and numerical chromosomal aberrations. The test material did not induce gene mutations in bacteria 
and was not clastogenic and/or aneugenic in mammalian cells in vitro. Although this commercial 
mixture was cytotoxic at high concentrations, the remaining concentrations without signs of toxicity 
provide a valid data set. 
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Conclusion 
The in vitro genotoxicity data on the commercial mixture of the representative substance 1(7),8-p-
menthadien-2-yl acetate [FL-no: 09.930] and a positional isomer, carvyl acetate do not indicate 
genotoxic potential. Accordingly the four substances in this subgroup 2.5 of FGE.19 (FGE.211) would 
be of no safety concern with respect to genotoxicity, and will then be evaluated through the Procedure. 
3.4. Genotoxicity Studies - Text taken from FGE.212Rev1 (EFSA, 2011f) 
The following text is taken from FGE.212Rev1 and is relevant for the evaluation of pin-2-en-4-ol [FL 
no: 02.101], which was one of the isophorone-related substances in subgroup 2.6 of FGE.19 
(FGE.212Rev1) for which a conclusion of no concern for genotoxicity was reached. 
There are studies available for four substances in this FGE (FGE.212Rev1). For tetramethyl 
ethylcyclohexenone (mixture of isomers) [FL-no: 07.035] one in vitro and one in vivo study have been 
evaluated. 
Seven in vitro and three in vivo studies are available for 3,5,5 trimethylcyclohex-2-en-1-one [FL-no: 
07.126] (isophorone). 
Three in vitro studies are available concerning d-carvone [FL-no: 07.146] and two in vitro studies 
concerning l-carvone [FL-no: 07.147]. 
Study validation and results are presented in Tables 5 and 6 of FGE.212Rev1. 
3,5,5-Trimethylcyclohex-2-en-1-one [FL-no: 07.126] (isophorone) did not induce gene mutations in 
bacteria but it induced mutations in mammalian cells in a mouse lymphoma TK assay in the absence 
of metabolic activation (it was not tested in the presence of metabolic activation) (NTP, 1986d). No 
mutations in the MLTK assay were observed in a study of O’Donoghue et al. (O’Donoghue et al., 
1988) at comparable concentrations. Isophorone induced chromosomal aberrations in Chinese hamster 
lung fibroblasts with and without metabolic activation (Matsuoka et al., 1996) and sister chromatid 
exchanges (SCE) in CHO cells without metabolic activation (Gulati et al., 1989). Chromosomal 
aberrations have not been observed in two other studies (Gulati et al., 1989; NTP, 1986d); however, 
the validity of the results was limited because the types of aberrations were not reported. Isophorone 
did not induce unscheduled DNA synthesis (UDS) in rat hepatocytes in vitro. In vivo, isophorone was 
tested negative in a sex-linked recessive lethal mutation assay in Drosophila (Foureman et al., 1994) 
and in two micronucleus assays in mice (McKee et al., 1987; O’Donoghue et al., 1988). However, the 
Drosophila assay has only limited relevance and the micronucleus assays were of limited validity. 
Negative results were also observed with tetramethyl ethylcyclohexenone [FL-no: 07.035] in bacteria, 
in a sex-linked recessive lethal mutation assay in Drosophila (Wild et al., 1983) and in a mouse 
micronucleus assay (Wild et al., 1983); however, there was a mixture of isomers tested and the studies 
were only of limited validity.  
d-Carvone [FL-no: 07.146] was not mutagenic in bacteria but induced SCE and chromosomal 
aberrations in CHO cells in the presence and absence of metabolic activation, respectively (NTP, 
1990b). 
Conclusion on Genotoxicity and Carcinogenicity (cited from FGE.212) 
The Panel concluded that 3,5,5 trimethylcyclohex-2-en-1-one [FL-no: 07.126] (isophorone) is 
genotoxic in vitro while a final conclusion on the genotoxicity in vivo could not be drawn based on the 
data available. It is carcinogenic in male rats and male mice. It was also predicted to be genotoxic in 
one of the four MultiCASE models (while it was out of domain in the ISS model). 
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d-Carvone [FL-no: 07.146] is genotoxic in vitro while no in vivo data were available. d-Carvone, was 
not carcinogenic in mice and was predicted to be non-genotoxic in the four MultiCASE models (while 
it was out of domain in the ISS model). No data are available on l-carvone. However, in vivo studies in 
humans show that the metabolism of ingestion-correlated amounts of d- or l-carvone occurs via a 
major oxidative pathway of the isopropylene side chain yielding diol and two carboxylic acids, 
irrespective of the stereochemical difference between the two parent isomers of carvone (Engel, 2001). 
Accordingly, the results for d-carvone can be used for l-carvone as well. 
The negative results reported from in vivo studies on the genotoxicity of tetramethyl 
ethylcyclohexenone [FL-no: 07.035] were only of limited validity. 
Data submitted from Industry in reply to Genotoxicity Data requested in FGE.212 (cited from the 
FGE.212Rev1) 
Honma et al. (Honma et al., 1999a; Honma et al., 1999b) found that isophorone did not clearly induce 
mutations in the mouse lymphoma assay (MLA) following 3 hour treatments, but observed that it was 
mutagenic after 24 hour treatments in the absence of S9. Although only graphs are plotted, it seems 
that increases in mutation frequency (MF) that exceeded the Global Evaluation Factor (GEF) occurred 
at around 1250‐1500 μg/ml where toxicity (by relative survival) reached 70 ‐ 90 %. 
The NTP conducted a mouse bone marrow chromosomal aberration (CA) study on isophorone. 
Groups of 8 male B6C3F1 mice (larger group sizes than required by OECD) were dosed i.p. with 
isophorone at 125, 250 and 500 mg/kg bw. The standard protocol for in vivo CA is not given on the 
NTP website. However, based on Shelby and Witt (Shelby and Witt, 1995), animals should have been 
sampled at 17 hours and, if negative, also at 36 hours. The data on the NTP website are only for bone 
marrow sampled at 36 hours It is therefore possible that a 17 hours sample was also taken, and found 
to be negative, but the data have not been posted. Fifty cells per animal were scored for CA and no 
increases in CA were seen. No measures of toxicity were recorded, but i.p. dosing should have 
guaranteed systemic exposure. The control CA frequency was normal (2.75 %) and the positive 
control (dimethylbenzanthracene) produced a significant response in CA frequency.  
A DNA binding study was conducted in which F344‐rats and B6C3F1‐mice (the strains used in the 
NTP carcinogenicity study) were exposed to isophorone (Thier et al., 1990). Animals of both sexes 
were dosed once or five times by gavage with 500 mg/kg bw of unlabelled isophorone spiked with 
[1,3,5‐14C]‐isophorone (specific activity: 52 mCi per mmol, 1.92 GBq per mmol). An additional group 
of acute dosed male rats received undiluted 14C‐isophorone for increased sensitivity. Rats and mice 
were maintained for 24 hours in closed metabolic cages. Twenty four hours after exposure, livers and 
kidneys (the tumour target tissues) were removed from the animals. DNA was isolated through 
hydroxyapatite chromatography and radioactivity was measured by liquid scintillation counting. No 
positive controls were included. Also no untreated controls were included, but, except for the liver 
sample of one mouse in the five times dose group, radioactivity values were within 2σ of background 
(6 dpm). Radioactivity values therefore did not indicate significant attachment of radioactivity to 
DNA. From these results it can be concluded that neither isophorone nor its metabolites bind 
covalently to DNA. 
A study (Morishita et al., 1997b) was designed to investigate whether isophorone and/or α2μ‐globulin5 
might be involved in the induction of preputial gland tumours in F‐344 rats (10/sex/dose group). A 
series of experiments was performed in order to study several parameters including: 
                                                     
 
5 Since interaction with α2μ-glubulin is not of direct relevance for the evaluation of genotoxic potential, this 
information is omitted from this study summary. 
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• Binding of isophorone to DNA of kidney and preputial gland. Groups of 10 male rats were dosed 
by gavage with 500 mg/kg of [14C]‐isophorone (specific activity 14.65 mCi/mmol; 100 
μCi/animal). Positive control animals were dosed with 3H‐labeled methyl nitrosourea. 
• DNA adduct detection by 32P‐postlabeling in young adult male and female rats (7 per group) 
dosed by gavage with 0, 250 or 500 mg/kg isophorone for five days. 
Extraction of preputial gland and kidney DNA from rats treated with single 500 mg/kg labeled doses 
yielded no evidence of isophorone binding to DNA, whereas the positive control showed significant 
binding to DNA of preputial gland and kidney. These negative results with isophorone were confirmed 
in the 32P ‐postlabeling assays.  
In addition Industry has also asked whether the information submitted for isophorone (cyclohexenyl 
derivative) could also be applied to evaluate the genotoxic potential of the five-carbon membered ring 
substances (i.e. cyclopentenyl derivatives) in subgroup 2.6 (letter of EFFA to EFSA, dated 14/4-2010) 
(EFFA, 2010f). This request was supported by the argumentation that there is structural resemblance 
with respect to steric hindrance around the alpha,beta-unsaturated double bond. In addition, Industry 
argued that the π-conjugation systems in these molecules is very nearly planar and that therefore the 
reactivity and genotoxic potentials of the five- and six-membered ring systems would be similar. No 
further data were provided to substantiate this argumentation. 
Discussion of the Additional Data (cited from the FGE.212Rev1) 
Conflicting results were reported in two valid studies with the mouse lymphoma assay (MLA): one 
negative (O’Donoghue et al., 1988) and one positive (NTP, 1986d) at comparable concentrations. 
Mixed results were also reported in two studies of limited validity: one negative (Honma et al., 1999a) 
and one positive (Honma et al., 1999b). Another negative result was reported in a study (McKee et al., 
1987), the validity of which cannot be evaluated. In the light of the clearly negative results in two 
valid bacterial gene mutation tests (Ames test) and in a valid Sex Linked Recessive Lethal Mutations 
test (SLRL) in Drosophila, and taking into account the lack of specificity and high sensitivity of the 
MLA, overall the results presently available are considered of questionable relevance. The Panel 
agrees that isophorone demonstrates some genotoxic activity in vitro but that the new data demonstrate 
lack of clastogenicity in vivo. In addition, the new DNA-binding data from two separate studies 
provide convincing evidence that isophorone does not induce tumours via a genotoxic mechanism. On 
the basis of these data it may be argued that there is no need to perform further in vivo genotoxicity 
studies such as the Comet assay or bone marrow micronucleus test. Thus, based on the data available 
the Panel concluded that there is no concern with respect to genotoxicity of isophorone. 
Since based on the additional information the concern for the genotoxic potential for isophorone has 
been alleviated, The Panel concluded in FGE212Rev1 that a genotoxic potential could also be ruled 
out for the other isophorone-related six-carbon members of this subgroup of FGE.19. 
3.5. EFSA Consideration  
For two of the candidate substances [FL-no: 02.100 and 02.101] it has been concluded in FGE.211 and 
FGE.212Rev1, respectively, that a concern for genotoxicity, indicated by the presence of a structural 
alert, could be ruled out based on experimental data for supporting substances. Thus, the Panel 
concluded that the two substances [FL-no: 02.100 and 02.101] can be evaluated through the Procedure 
in this FGE.87Rev1. For the remaining 15 candidate substances in FGE.87Rev1 [FL-no: 02.016, 
02.038, 02.059, 07.153, 07.159, 09.017, 09.082, 09.131, 09.153, 09.176, 09.218, 09.269, 09.319, 
09.456 and 09.457], genotoxicity data are available on two substances [FL-no: 02.016 and 09.131]. 
The genotoxicity of these two substances could not be adequately assessed. However, the data 
available do not preclude the evaluation of these 15 candidate substances using the Procedure. 
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4. Application of the Procedure 
4.1. Application of the Procedure to 17 Bicyclic Secondary Alcohols, Ketones and related 
Esters by the JECFA (JECFA, 2006a) 
According to the JECFA, 15 of the 17 substances belong to structural class I and two to structural 
class II using the decision tree approach presented by Cramer et al. (Cramer et al., 1978). 
The JECFA concluded the 17 bicyclic secondary alcohols, ketones and related esters at step A3 in the  
JECFA Procedure, i.e. the substances are expected to be metabolised to innocuous products (step 2) 
and concluded that the intakes for all substances are below the thresholds for their structural classes I 
and II (step A3).  
In conclusion, the JECFA considered that the bicyclic secondary alcohols, ketones and related esters 
evaluated through the Procedure, were of no safety concern at the estimated levels of intakes based on 
the MSDI approach. 
The evaluations of the bicyclic secondary alcohols, ketones and related esters are summarised in Table 
3.1: Summary of Safety Evaluation of Bicyclic Secondary Alcohols, Ketones and Related Esters 
(JECFA, 2006a). 
4.2. Application of the Procedure to Four Bicyclic Secondary Alcohols, Ketones and Related 
Esters by EFSA in FGE.47 (EFSA, 2008at) 
Step 1 
Three of the four candidate substances are classified into structural class I and one into structural class 
II according to the decision tree approach as presented by Cramer et al. (Cramer et al., 1978). 
Step 2 
All four candidate substances in this group are expected to be metabolised to innocuous products. The 
evaluation of these substances therefore proceeded via the A-side of the evaluation scheme. 
Step A3 
The estimated per capita daily intakes for all four candidate substances classified in structural classes I 
and II are below the human intake threshold of concern (i.e. 1800 μg/person per day for class I and 
540 μg/person per day for class II).  
Based on results of the safety evaluation sequence of the Procedure, these four candidate substances, 
preceding via the A-side of the Procedure, do not pose a safety concern when used as flavouring 
substances at the estimated levels of intake, based on the MSDI approach. 
4.3. EFSA Considerations  
The Panel agrees with the application of the Procedure as performed by the JECFA for the bicyclic 
secondary alcohols, ketones and related esters. It was concluded at step A3 of the Procedure that the 
17 substances do not pose a safety concern when used as flavouring substances at estimated levels of 
intake, based on the MSDI approach. 
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5. Conclusion 
The Panel concluded that all the 17 substances in the JECFA flavouring group of bicyclic secondary 
alcohols, ketones and related esters are structurally related to the group of four bicyclic secondary 
alcohols, ketones and related evaluated by EFSA in the Flavouring Group Evaluation 47 (FGE.47). 
The Panel agrees with the application of the Procedure as performed by the JECFA for the bicyclic 
secondary alcohols, ketones and related esters. It was concluded at step A3 of the Procedure that the 
17 substances do not pose a safety concern when used as flavouring substances at estimated levels of 
intake, based on the MSDI approach. 
For all 17 substances use levels are needed to calculate the mTAMDIs in order to identify those 
flavouring substances that need more refined exposure assessments and to finalise the evaluation. 
In order to determine whether the conclusion for the JECFA-evaluated substances can be applied to 
the materials of commerce, it is necessary to consider the available specifications. Specifications are 
available for all the materials of commerce. For two of the candidate substances [FL-no: 02.100 and 
02.101] the stereoisomeric composition has not been specified.  Thus, for two JECFA-evaluated 
bicyclic secondary alcohols, ketones and related esters [FL-no: 02.100 and 02.101] the Panel has 
reservations (information on the stereoisomeric composition of is lacking). 
For the remaining 15 JECFA-evaluated bicyclic secondary alcohols, ketones and related esters [FL-no: 
02.016, 02.038, 02.059, 07.153, 07.159, 09.017, 09.082, 09.131, 09.153, 09.176, 09.218, 09.269, 
09.319, 09.456 and 09.457] the Panel agrees with the JECFA conclusion: “No safety concern at 
estimated levels of intake as flavouring substances” based on the MSDI approach.   
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TABLE 1: SPECIFICATION SUMMARY  
Table 1: Specifications Summary for the JECFA Evaluated Substances in the Present Group (JECFA, 2005b) 
Table 1: Specification Summary of the Substances in the JECFA Flavouring Group of Bicyclic Secondary Alcohols, Ketones and Related Esters (JECFA, 2005b) 
FL-no 
JECFA-
no 
EU Register name Structural formula FEMA no 
CoE no 
CAS no 
Phys.form 
Mol.formula 
Mol.weight 
Solubility 1) 
Solubility in ethanol 
2) 
Boiling point, °C 
3) 
Melting point, °C 
ID test 
Assay minimum 
Refrac. 
Index 4) 
Spec.gravity 
5) 
EFSA comments 
02.016 
1385 
Borneol 
HO
_____
OH
_____
 
2157 
64 
507-70-0 
Solid 
C10H18O 
154.25 
Very slightly soluble 
Soluble 
n.a. 
202 
IR 
97 % 
n.a. 
n.a. 
 
Racemate (±) = DL-Borneol 
(EFFA, 2010a).  
CASrn refers to (1R,2S,4R)-
rel. Register name to be 
changed to DL-Borneol 
(EFFA, 2011m). 
According to JECFA "Min. 
Assay value may incl. 
Isoborneol, other isomers of 
borneol, trace amounts of 
fenchyl alcohol & other 
C10H18O compounds".  
02.038 
1397 
Fenchyl alcohol 
OH
 
2480 
87 
1632-73-1 
Solid 
C10H18O 
154.25 
Very slightly soluble 
Soluble 
n.a. 
35-40 
IR 
97 % 
n.a. 
n.a. 
 
Racemate (EFFA, 2010a). 
According to JECFA "Min. 
Assay value is (97 %) of 
C10H18O which may include 
small amounts of borneol 
and isoborneol". 
02.059 
1386 
Isoborneol 
HO
_____
OH
_____
 
2158 
2020 
124-76-5 
Solid 
C10H18O 
154.25 
Very slightly soluble 
Soluble 
n.a. 
212-214 
IR 
92 % 
n.a. 
n.a. 
 
Racemate (±) = DL-
isoborneol (EFFA, 2011m). 
CASrn in Register refers to 
(1R,2R,4R)-rel. Register 
name to be changed to DL-
Isoborneol (EFFA, 2011m). 
According to JECFA: Min. 
assay value is "92 %" and 
secondary components "3-5 
% borneol". 
02.100 
1403 
Pinocarveol   6) 
HO
 
3587 
10303 
5947-36-4 
Liquid 
C10H16O 
152.24 
Insoluble 
Soluble 
210 
 
NMR 
95 % 
1.445-1.451 
0.977-0.983 
 
Composition of 
stereoisomeric mixture to be 
specified. 
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Table 1: Specification Summary of the Substances in the JECFA Flavouring Group of Bicyclic Secondary Alcohols, Ketones and Related Esters (JECFA, 2005b) 
FL-no 
JECFA-
no 
EU Register name Structural formula FEMA no 
CoE no 
CAS no 
Phys.form 
Mol.formula 
Mol.weight 
Solubility 1) 
Solubility in ethanol 
2) 
Boiling point, °C 
3) 
Melting point, °C 
ID test 
Assay minimum 
Refrac. 
Index 4) 
Spec.gravity 
5) 
EFSA comments 
02.101 
1404 
Pin-2-en-4-ol   6) HO
 
3594 
10304 
473-67-6 
Solid 
C10H16O 
152.24 
Very slightly soluble 
Soluble 
n.a. 
63-67 
NMR 
95 % 
n.a. 
n.a. 
 
Composition of 
stereoisomeric mixture to be 
specified. 
07.153 
1407 
1,10-Dihydronootkatone O
 
3776 
 
20489-53-6 
Liquid 
C15H24O 
220.36 
Very slightly soluble 
Soluble 
100-104(0.09hPa 
 
NMR 
90 % 
1.502-1.508 
0.975-0.988 
 
CASrn in Register refers to 
(4R,4aS,6R,8aS)-
stereoisomer. Register name 
to be changed accordingly. 
According to JECFA "Min. 
assay value is (90 %) and 
secondary components (5-
6% nootkatone)". 
07.159 
1396 
d-Fenchone 
O
 
2479 
551 
4695-62-9 
Liquid 
C10H16O 
152.24 
Insoluble 
Soluble 
192 
 
IR 
97 % 
1.460-1.467 
0.940-0.948 
 
D-(+)-Fenchone (EFFA, 
2010a). CASrn in Register 
refers to (1S,4R)-isomer. 
According to JECFA "Min. 
Assay value is "97 % of 
C10H16O" which may 
include small amounts of d-
camphor". 
09.017 
1387 
Bornyl acetate 
O
O
O
O
 
2159 
207 
76-49-3 
Liquid 
C12H20O2 
196.29 
Slightly soluble 
Soluble 
226 
25 
IR 
98 % 
1.462-1.466 
0.981-0.985 
 
Racemate (±) = DL-Bornyl 
acetate (EFFA, 2010a). 
CASrn in Register refers to 
(1R,2S,4R)-rel. Register 
name to be changed to DL-
Bornyl acetate (EFFA, 
2011m). 
According to JECFA "Min. 
Assay value is 98 % and 
may include isobornyl 
acetate and other bornyl 
acetate isomers".  
09.082 
1389 
Bornyl formate 
O
_____O
O
_____ O
 
2161 
349 
7492-41-3 
Liquid 
C11H18O2 
182.26 
Slightly soluble 
Soluble 
106-108 (27hPa) 
 
NMR 
95 % 
1.466-1.472 
1.007-1.013 
(20°) 
 
Racemate (±) = DL-Bornyl 
formate (EFFA, 2011m) 
CASrn in Register refers to 
(1R,2S,4R)-rel. Register 
name to be changed to DL-
Bornyl formate (EFFA, 
2011m). 
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Table 1: Specification Summary of the Substances in the JECFA Flavouring Group of Bicyclic Secondary Alcohols, Ketones and Related Esters (JECFA, 2005b) 
FL-no 
JECFA-
no 
EU Register name Structural formula FEMA no 
CoE no 
CAS no 
Phys.form 
Mol.formula 
Mol.weight 
Solubility 1) 
Solubility in ethanol 
2) 
Boiling point, °C 
3) 
Melting point, °C 
ID test 
Assay minimum 
Refrac. 
Index 4) 
Spec.gravity 
5) 
EFSA comments 
09.131 
1391 
Isobornyl propionate 
O
_____O
O
_____ O
 
2163 
412 
2756-56-1 
Liquid 
C13H22O2 
210.32 
Soluble 
Soluble 
245 
 
NMR 
97 % 
1.461-1.465 
0.968-0.971 
 
Racemate (±) = DL-
Isobornyl propionate 
(EFFA, 2010a). CASrn in 
Register refers to 
(1R,2R,4R)-rel. Register 
name to be changed to DL-
Isobornyl propionate 
(EFFA, 2011m).  
According to JECFA "Min. 
Assay value may include 
small amounts of bornyl 
propionate".  
09.153 
1392 
Bornyl valerate 
O
_____
O
O
_____
O
 
2164 
471 
7549-41-9 
Liquid 
C15H26O2 
238.37 
Insoluble 
Soluble 
136-137 (16hPa) 
 
NMR 
96 % 
1.459-1.465 
0.957-0.963 
 
Racemate (±) = DL-Bornyl 
valerate (EFFA, 2010a). 
CASrn in Register refers to 
(1R,2S,4R)-rel. Register 
name to be changed to DL-
Bornyl valerate (EFFA, 
2011m). 
According to JECFA: Min. 
assay value "may include 
small amounts of isobornyl 
valerate". 
09.176 
1390 
Isobornyl formate 
O
_____O
O
_____ O
 
2162 
565 
1200-67-5 
Liquid 
C11H18O2 
182.26 
Slightly soluble 
Soluble 
94-95 (20 hPa) 
 
NMR 
96 % 
1.469-1.473 
1.011-1.017 
 
Racemate (±) = DL- 
Isobornyl formate (EFFA, 
2010a). CASrn in Register 
refers to (1R,2R,4R)-rel. 
Register name to be changed 
to DL-Isobornyl formate 
(EFFA, 2011m).  
According to JECFA: Min. 
Assay value "may include 
small amounts of bornyl 
formate".  
09.218 
1388 
Isobornyl acetate 
O
_____O
O
_____ O
 
2160 
2066 
125-12-2 
Liquid 
C12H20O2 
196.29 
Insoluble 
Soluble 
227 
 
IR 
97 % 
1.462-1.465 
0.979-0.984 
 
Racemate (±) = DL-
Isobornyl acetate (EFFA, 
2010a). CASrn in Register 
refers to (1R,2R,4R)-rel. 
Register name to be changed 
to DL-Isobornyl acetate 
(EFFA, 2011m).  
Flavouring Group Evaluation 87, Revision 1
 
EFSA Journal 2012;10(2):2564 19
Table 1: Specification Summary of the Substances in the JECFA Flavouring Group of Bicyclic Secondary Alcohols, Ketones and Related Esters (JECFA, 2005b) 
FL-no 
JECFA-
no 
EU Register name Structural formula FEMA no 
CoE no 
CAS no 
Phys.form 
Mol.formula 
Mol.weight 
Solubility 1) 
Solubility in ethanol 
2) 
Boiling point, °C 
3) 
Melting point, °C 
ID test 
Assay minimum 
Refrac. 
Index 4) 
Spec.gravity 
5) 
EFSA comments 
According to JECFA "Min. 
Assay value may include 
small amounts of bornyl 
acetate". 
09.269 
1399 
Fenchyl acetate 
O
O
 
3390 
11769 
13851-11-1 
Liquid 
C12H20O2 
196.29 
Slightly soluble 
Soluble 
220 
 
NMR 
98 % 
1.456-1.462 
0.973-0.979 
 
Racemate. 
(CASrn in Register refers to 
the racemate). 
 
 
09.319 
1412 
Bornyl butyrate 
O
_____ O
O
_____O
 
3907 
 
13109-70-1 
Liquid 
C14H24O2 
224.34 
Slightly soluble 
Soluble 
247 
 
MS 
97 % 
1.462-1.469 
0.981-0.991 
 
Racemate (±) = DL-Bornyl 
butyrate. CASrn in Register 
refers to (1R,2S,4R)-rel. 
Register name to be changed 
to DL-Bornyl butyrate 
(EFFA, 2011m). 
09.456 
1393 
Bornyl isovalerate 
O
_____O
O
_____ O
 
2165 
451 
76-50-6 
Liquid 
C15H26O2 
238.37 
Insoluble 
Soluble 
260 
 
NMR 
97 % 
1.458-1.461 
0.944-0.947 
 
Racemate (±) = DL-Bornyl 
isovalerate. CASrn in 
Register refers to 
(1R,2S,4R)-rel. Register 
name to be changed to DL-
Bornyl isovalerate (EFFA, 
2011m). 
 
 
09.457 
1394 
Isobornyl isovalerate 
O
_____O
O
_____ O
 
2166 
452 
7779-73-9 
Liquid 
C15H26O2 
238.37 
Insoluble 
Soluble 
266-269 
 
NMR 
96 % 
1.463-1.469 
0.900-0.906 
 
Racemate (±) = DL-
Isobornyl isovalerate. 
CASrn in Register refers to 
(1R,2R,4R)-rel. Register 
name to be changed to DL-
Isobornyl isovalerate 
(EFFA, 2011m). 
1) Solubility in water, if not otherwise stated. 
2) Solubility in 95 %  ethanol, if not otherwise stated. 
3) At 1013.25 hPa, if not otherwise stated. 
4) At 20°C, if not otherwise stated. 
5) At 25°C, if not otherwise stated. 
6) Stereoisomeric composition not specified. 
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TABLE 2: GENOTOXICITY DATA  
Table 2.1: Summary of Genotoxicity Data of Bicyclic Secondary Alcohols, Ketones and Related Esters Evaluated by the JECFA (JECFA, 2006a) 
FL-no 
JECFA-
no 
EU Register name 
JECFA name 
Structural formula End-point Test system Concentration Results Reference 
In vitro 
02.016 
1385 
Borneol 
OH
_____
 
Reverse mutation S. typhimurium TA97, TA98, 
TA100 
1 mg/ml (1000 µg/ml) Negative1 (Azizan and Blevins, 1995) 
Reverse mutation S. typhimurium TA98, TA100, 
TA1535, TA1537, TA1538 
≤ 5 mg/plate 
(5000µg/plate) 
Negative1 (Simmon et al., 1977) 
DNA repair B. subtilis M45- and H17+ ≤ 10mg/disc Positive (Yoo, 1986) 
Mutation test E. coli WP2 uvrA (trp-) 0.4-3.2 mg/plate Negative (Yoo, 1986) 
09.131 
1391 
Isobornyl propionate 
O
_____O
Reverse mutation S. typhimurium TA98, TA100, 
TA1535, TA1537, TA1538 
≤ 3.6 mg/plate  
(3600 µg/plate) 
Negative1 (Wild et al., 1983) 
In vivo 
09.131 
1391 
Isobornyl propionate 
O
_____O
 
Somatic mutation and 
recombination 
D. melanogaster 10 mmol/l (2103 µg/ml) Negative2 (Wild et al., 1983) 
Micronucleus formation Mouse bone marrow cells 841, 1893 and 2944 
mg/kg bw 
Negative3 (Wild et al., 1983) 
1 Tested with and without metabolic activation. 
2 Dose calculated based on the relative molecular mass of substance = 210.32. 
3 Administered via intraperitoneal injection. 
 
No in vitro / in vivo genotoxicity data are available for the candidate substances in FGE.47 (EFSA, 2008at). 
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Table 3: Summary of Safety Evaluations 
Table 3.1: Summary of Safety Evaluation of Bicyclic Secondary Alcohols, Ketones and Related Esters (JECFA, 2006a) 
Table 3.1: Summary of Safety Evaluation of Bicyclic Secondary Alcohols, Ketones and Related Esters (JECFA, 2006a) 
FL-no 
JECFA-no 
EU Register name Structural formula EU MSDI 1)  
US MSDI 
(μg/capita/day) 
 
Class 2) 
Evaluation procedure 
path 3) 
Outcome on the 
named compound  
[4) or 5)] 
EFSA conclusion on the 
named compound 
(Procedure steps, intake 
estimates, NOAEL, 
genotoxicity) 
 
EFSA conclusion on the 
material of commerce 
02.016 
1385 
Borneol 
HO
_____
OH
_____
 
130 
23 
Class I 
A3: Intake below threshold 
4) No safety concern at the 
estimated level of intake 
based on the MSDI 
approach. 
Register name to be 
changed to DL-Borneol. 
No safety concern at the 
estimated level of intake 
based on the MSDI 
approach. 
02.038 
1397 
Fenchyl alcohol 
OH
 
55 
17 
Class I 
A3: Intake below threshold 
4) No safety concern at the 
estimated level of intake 
based on the MSDI 
approach. 
No safety concern at the 
estimated level of intake 
based on the MSDI 
approach. 
02.059 
1386 
Isoborneol 
HO
_____
OH
_____
 
21 
0.07 
Class I 
A3: Intake below threshold 
4) No safety concern at the 
estimated level of intake 
based on the MSDI 
approach. 
Register name to be 
changed to DL-Isoborneol. 
No safety concern at the 
estimated level of intake 
based on the MSDI 
approach. 
 
02.100 
1403 
Pinocarveol 
HO
0.012 
0.01 
Class I 
A3: Intake below threshold 
4) Evaluated in FGE.211, 
genotoxicity concern could 
be ruled out. 
Composition of 
stereoisomeric mixture to 
be specified. 
02.101 
1404 
Pin-2-en-4-ol HO
 
0.012 
0.2 
Class I 
A3: Intake below threshold 
4) Evaluated in 
FGE.212Rev1, genotoxic 
concern could be ruled out.  
Composition of 
stereoisomeric mixture to 
be specified. 
09.017 
1387 
Bornyl acetate 
O
O
O
O
 
18 
3 
Class I 
A3: Intake below threshold 
4) No safety concern at the 
estimated level of intake 
based on the MSDI 
approach. 
Register name to be 
changed to DL-Bornyl 
acetate. 
No safety concern at the 
estimated level of intake 
based on the MSDI 
approach. 
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Table 3.1: Summary of Safety Evaluation of Bicyclic Secondary Alcohols, Ketones and Related Esters (JECFA, 2006a) 
FL-no 
JECFA-no 
EU Register name Structural formula EU MSDI 1)  
US MSDI 
(μg/capita/day) 
 
Class 2) 
Evaluation procedure 
path 3) 
Outcome on the 
named compound  
[4) or 5)] 
EFSA conclusion on the 
named compound 
(Procedure steps, intake 
estimates, NOAEL, 
genotoxicity) 
 
EFSA conclusion on the 
material of commerce 
09.082 
1389 
Bornyl formate 
O
_____O
O
_____ O
 
1.2 
0.09 
Class I 
A3: Intake below threshold 
4) No safety concern at the 
estimated level of intake 
based on the MSDI 
approach. 
Register name to be 
changed to DL-Bornyl 
formate. 
No safety concern at the 
estimated level of intake 
based on the MSDI 
approach. 
09.131 
1391 
Isobornyl propionate 
O
_____O
O
_____ O
 
2.6 
0.007 
Class I 
A3: Intake below threshold 
4) No safety concern at the 
estimated level of intake 
based on the MSDI 
approach. 
Register name to be 
changed to DL-Isobornyl 
propionate. 
No safety concern at the 
estimated level of intake 
based on the MSDI 
approach. 
09.153 
1392 
Bornyl valerate 
O
_____
O
O
_____
O
3.7 
5 
Class I 
A3: Intake below threshold 
4) No safety concern at the 
estimated level of intake 
based on the MSDI 
approach. 
Register name to be 
changed to DL-Bornyl 
valerate. 
No safety concern at the 
estimated level of intake 
based on the MSDI 
approach. 
 
09.176 
1390 
Isobornyl formate 
O
_____O
O
_____ O
 
0.61 
0.4 
Class I 
A3: Intake below threshold 
4) No safety concern at the 
estimated level of intake 
based on the MSDI 
approach. 
Register name to be 
changed to DL-Isobornyl 
formate. 
No safety concern at the 
estimated level of intake 
based on the MSDI 
approach. 
 
09.218 
1388 
Isobornyl acetate 
O
_____O
O
_____ O
 
890 
236 
Class I 
A3: Intake below threshold 
4) No safety concern at the 
estimated level of intake 
based on the MSDI 
approach. 
Register name to be 
changed to DL-Isobornyl 
acetate. 
No safety concern at the 
estimated level of intake 
based on the MSDI 
approach. 
09.269 
1399 
Fenchyl acetate 
O
O
2.9 
0.07 
Class I 
A3: Intake below threshold 
4) No safety concern at the 
estimated level of intake 
based on the MSDI 
approach. 
No safety concern at the 
estimated level of intake 
based on the MSDI 
approach. 
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Table 3.1: Summary of Safety Evaluation of Bicyclic Secondary Alcohols, Ketones and Related Esters (JECFA, 2006a) 
FL-no 
JECFA-no 
EU Register name Structural formula EU MSDI 1)  
US MSDI 
(μg/capita/day) 
 
Class 2) 
Evaluation procedure 
path 3) 
Outcome on the 
named compound  
[4) or 5)] 
EFSA conclusion on the 
named compound 
(Procedure steps, intake 
estimates, NOAEL, 
genotoxicity) 
 
EFSA conclusion on the 
material of commerce 
09.319 
1412 
Bornyl butyrate 
O
_____ O
O
_____O
 
6.1 
9 
Class I 
A3: Intake below threshold 
4) No safety concern at the 
estimated level of intake 
based on the MSDI 
approach. 
CASrn in Register refers to 
(1R,2S,4R)-rel. Register 
name to be changed to DL-
Bornyl butyrate. 
No safety concern at the 
estimated level of intake 
based on the MSDI 
approach. 
09.456 
1393 
Bornyl isovalerate 
O
_____O
O
_____ O
 
0.12 
0.5 
Class I 
A3: Intake below threshold 
4) No safety concern at the 
estimated level of intake 
based on the MSDI 
approach. 
Register name to be 
changed to DL-Bornyl 
isovalerate. 
No safety concern at the 
estimated level of intake 
based on the MSDI 
approach. 
 
09.457 
1394 
Isobornyl isovalerate 
O
_____O
O
_____ O
 
0.012 
0.08 
Class I 
A3: Intake below threshold 
4) No safety concern at the 
estimated level of intake 
based on the MSDI 
approach. 
Register name to be 
changed to DL-Isobornyl 
isovalerate. 
No safety concern at the 
estimated level of intake 
based on the MSDI 
approach. 
 
07.153 
1407 
1,10-Dihydronootkatone O
 
0.24 
0.9 
Class II 
A3: Intake below threshold 
4) No safety concern at the 
estimated level of intake 
based on the MSDI 
approach. 
CASrn refers to 
(4R,4aS,6R,8aS)-
stereoisomer. Register 
name to be changed 
accordingly. 
No safety concern at the 
estimated level of intake 
based on the MSDI 
approach. 
 
07.159 
1396 
d-Fenchone 
O
 
6 
5 
Class II 
A3: Intake below threshold 
4) No safety concern at the 
estimated level of intake 
based on the MSDI 
approach. 
No safety concern at the 
estimated level of intake 
based on the MSDI 
approach. 
 
1) EU MSDI: Amount added to food as flavour in (kg / year) x 10E9 / (0.1 x population in Europe (= 375 x 10E6) x 0.6 x 365)  =  µg/capita/day 
2) Thresholds of concern: Class I = 1800, Class II = 540, Class III = 90 µg/person/day 
3) Procedure path A substances can be predicted to be metabolised to innocuous products.  Procedure path B substances cannot. 
4) No safety concern based on intake calculated by the MSDI approach of the named compound. 
5) Data must be available on the substance or closely related substances to perform a safety evaluation. 
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Table 3.2: Summary of Safety Evaluation Applying the Procedure (EFSA / FGE.47) 
Table3.2: Summary of Safety Evaluation Applying the Procedure (based on intakes calculated by the MSDI approach) 
FL-no EU Register name Structural formula MSDI 1)  
(μg/capita/day) 
Class 2) 
Evaluation procedure path 
3) 
Outcome on the named 
compound  
[4) or 5)] 
Outcome on the 
material of 
commerce [6), 7), 
or 8)] 
Evaluation remarks 
09.584 
 
Isobornyl isobutyrate 
O
O
O
O
0.085 
 
Class I 
A3: Intake below threshold 
4) 7)  
09.848 
 
(1S-endo)-1,7,7-
Trimethylbicyclo[2.2.1]heptan-2-ol 
acetate 
O
_____O
0.011 
 
Class I 
A3: Intake below threshold 
4) 7)  
09.888 
 
Isobornyl 2-methylbutyrate 
O
_____O
0.061 
 
Class I 
A3: Intake below threshold 
4) 7)  
07.171 
 
Isopinocamphone 
O
0.024 
 
Class II 
A3: Intake below threshold 
4) 7)  
1) EU MSDI: Amount added to food as flavour in (kg / year) x 10E9 / (0.1 x population in Europe (= 375 x 10E6) x 0.6 x 365)  =  µg/capita/day. 
2) Thresholds of concern: Class I = 1800 µg/person/day, Class II = 540 µg/person/day, Class III = 90 µg/person/day. 
3) Procedure path A substances can be predicted to be metabolised to innocuous products.  Procedure path B substances cannot. 
4) No safety concern based on intake calculated by the MSDI approach of the named compound. 
5) Data must be available on the substance or closely related substances to perform a safety evaluation. 
6) No safety concern at estimated level of intake of the material of commerce meeting the specification of Table 1 (based on intake calculated by the MSDI approach). 
7) Tentatively regarded as presenting no safety concern (based on intake calculated by the MSDI approach) pending further information on the purity of the material of commerce and/or information on stereoisomerism. 
8) No conclusion can be drawn due to lack of information on the purity of the material of commerce. 
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ABBREVIATIONS 
BW  Body weight 
CA  Chromosomal Aberration 
CAS  Chemical Abstract Service 
CEF  Panel on Food Contact Materials, Enzymes, Flavourings and Processing Aids 
CHO  Chinese hamster ovary (cells) 
CoE  Council of Europe 
DNA  Deoxyribonucleic acid 
EFSA  The European Food Safety Authority 
EPA  United States Environmental Protection Agency  
EU  European Union 
FAO  Food and Agriculture Organization of the United Nations  
FEMA  Flavor and Extract Manufacturers Association 
FGE  Flavouring Group Evaluation  
FLAVIS (FL) Flavour Information System (database) 
GEF  Global Evaluation Factor  
GLP  Good laboratory practise 
ID  Identity 
Ip  Intraperitoneal 
IR  Infrared spectroscopy 
JECFA  The Joint FAO/WHO Expert Committee on Food Additives 
MLA  Mouse Lymphoma Assay 
MNBN  Micronucleated Binucleate Cells 
MSDI  Maximised Survey-derived Daily Intake 
mTAMDI Modified Theoretical Added Maximum Daily Intake 
MF  Mutation Frequency (MF)  
NCE  Normochromatic Erythrocyte 
No  Number 
NOAEL No observed adverse effect level 
Flavouring Group Evaluation 87, Revision 1
 
EFSA Journal 2012;10(2):2564 31
NTP  National Toxicology Program 
OECD  Organisation for Economic Co-operation and Development 
PCE  Polychromatic erythrocyte 
SCE  Sister chromatic exchange 
SCF  Scientific Committee on Food 
SLRL  Sex Linked Recessive Lethal Mutations test 
UDS  Unscheduled DNA Synthesis (UDS) 
WHO  World Health Organisation 
